The impact of surgical site infection on hospitalisation, treatment costs, and health-related quality of life after vascular surgery.

Autor: Totty JP; Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK.; Department of Plastic and Reconstructive Surgery, Castle Hill Hospital, Cottingham, UK., Moss JWE; York Health Economics Consortium, University of York, York, UK., Barker E; York Health Economics Consortium, University of York, York, UK., Mealing SJ; York Health Economics Consortium, University of York, York, UK., Posnett JW; Independent health economics consultant, York, UK., Chetter IC; Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK., Smith GE; Academic Vascular Surgical Unit, Hull York Medical School, Hull, UK.
Jazyk: angličtina
Zdroj: International wound journal [Int Wound J] 2021 Jun; Vol. 18 (3), pp. 261-268. Date of Electronic Publication: 2020 Dec 16.
DOI: 10.1111/iwj.13526
Abstrakt: Surgical site infections (SSI) substantially increase costs for healthcare providers because of additional treatments and extended patient recovery. The objective of this study was to assess the cost and health-related quality of life impact of SSI, from the perspective of a large teaching hospital in England. Data were available for 144 participants undergoing clean or clean-contaminated vascular surgery. SSI development, length of hospital stay, readmission, and antibiotic use were recorded over a 30-day period. Patient-reported EQ-5D scores were obtained at baseline, day 7 and day 30. Linear regressions were used to control for confounding variables. A mean SSI-associated length of stay of 9.72 days resulted in an additional cost of £3776 per patient (including a mean antibiotic cost of £532). Adjusting for age, smoking status, and procedure type, SSI was associated with a 92% increase in length of stay (P < 0.001). The adjusted episode cost was £3040. SSI reduced patient utility between baseline and day 30 by 0.156 (P = 0.236). Readmission rates were higher with SSI (P = 0.017), and the rate to return to work within 90 days was lower. Therefore, strategies to reduce the risk of surgical site infection for high-risk vascular patients should be investigated.
(© 2020 The Authors. International Wound Journal published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: